Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and the Keck ...
Rutland Herald

Tempus to Report First Quarter 2026 Financial Results on May 5

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it will report financial results for the first quarter ended March 31, ...
News-Medical.Net

USC and Tempus AI partner to advance precision medicine

The Keck School of Medicine of USC and Keck Medicine of USC have launched collaborations with Tempus AI, Inc., a technology company at the forefront of applying AI to precision medicine, to integrate ...
Becker's Hospital Review

Keck Medicine, Tempus AI ink precision medicine partnership

Tempus AI and the University of Southern California in Los Angeles have launched a collaboration to advance precision medicine using artificial intelligence. The partnership will integrate AI-driven ...

Tempus AI Inc. (TEM): Nancy Pelosi Likes This AI-Powered Medicine Company

A regulatory filing dated late January 2026 shows that Nancy Pelosi exercised 50 CALL options on Tempus AI, Inc. (NASDAQ:TEM) ...
Business Wire

Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that it will participate in the Morgan Stanley ...
Business Wire

Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, will present at ...

Gilead (GILD), Tempus AI (TEM) expand multi-year oncology R&D collaboration

Gilead Sciences Inc. (NASDAQ:GILD) is one of the 8 Best Quality Stocks to Buy According to Hedge Funds. Gilead Sciences Inc. ...

Tempus Launches Automated "Active Follow-Up" Service to Support Guideline-Concordant Care

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...
The Caledonian-Record

Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Predicta Biosciences, a precision oncology company developing novel diagnostic ...

Tempus AI Shares Gain on Commercial Partnership With Predicta Biosciences

Shares of Tempus AI rose after the medical technology company said it was expanding the commercial availability of whole-genome sequencing assay technology to detect and analyze cancer cells in ...
Seeking Alpha

Tempus to Participate in the Morgan Stanley Technology, Media and Telecom Conference

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the Morgan Stanley Technology, ...